A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

• Príomhchruthaitheoirí: Daniela Chirio (Údar), Elena Peira (Údar), Simona Sapino (Údar), Giulia Chindamo (Údar), Simonetta Oliaro-Bosso (Údar), Salvatore Adinolfi (Údar), Chiara Dianzani (Údar), Francesca Baratta (Údar), Marina Gallarate (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2021-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...